More than 260 government and industry representatives gathered at POWERCHINA headquarters in Beijing this month to unlock R2.2 trillion in energy investments. Under South Africa’s Integrated Resource Plan 2025, the initiative aims to overhaul the nation’s power grid through 2039, focusing on generation, transmission, and large-scale infrastructure development.
With a three-year revenue growth rate of 830%, Bask & Lather Co. has secured the 355th spot on the 2026 Inc. 5000 list. The ranking, which tracks the fastest-growing private companies in the United States, highlights the brand’s rapid expansion from a family-inspired startup to a major player in the haircare industry.
A securities class action has been filed against PROCEPT BioRobotics Corporation following allegations that the company inflated its financial performance through undisclosed discount programs. Investors who purchased common stock between February 28, 2024, and February 25, 2026, now face a September 22, 2026, deadline to seek appointment as lead plaintiff.
Shareholders of Cardinal Health are set to receive a quarterly dividend of $0.5158 per share, following formal approval from the company’s Board of Directors. This payout, drawn from the firm’s capital surplus, continues the Dublin-based distributor’s commitment to returning value to its investors this fiscal year.
A prolonged deadlock between shareholders has ended with Hong Kong-based Gravity Capital taking over the 70.3% stake previously held by Versorgungswerk der Zahnärzte Berlin (VZB) in Grand Metropolitan Hotels Holding B.V. The transaction, finalized on June 30, 2026, marks a complete separation from the former joint venture structure.
The global online language learning market is projected to reach 50.82 billion dollars by 2031, surging from its current valuation of 24.39 billion dollars. This expansion, representing a compound annual growth rate of 15.83 percent, is fueled by a combination of cross-border communication demands and rapid mobile technology adoption.
Blue Moon Metals has acquired 33 tungsten and antimony projects across the western United States, aiming to consolidate domestic production of critical minerals. The portfolio, purchased from a private owner, includes historically productive sites that have seen minimal modern exploration, offering a strategic boost to the company’s existing Nevada-based operations.
Monogram Capital Partners has finalized a single-asset continuation vehicle for Mountaintop Beverage, a deal led by Apollo S3 that returns substantial capital to original investors while securing fresh funding for the Morgantown, West Virginia, manufacturer’s aggressive expansion plans in the aseptic beverage sector.
Cardinal Health reported a robust fiscal year 2026, with annual revenues climbing 14% to $254.2 billion. The company’s non-GAAP diluted earnings per share surged 37% to $11.26, fueled by double-digit profit growth across all five of its operating segments and disciplined strategic execution.
A long-standing deadlock between Kingstone Capital AG and the Versorgungswerk der Zahnärzte Berlin (VZB) has dissolved, as Gravity Capital Hong Kong stepped in to acquire the 70.3% stake in Grand Metropolitan Hotels Holding B.V. The transaction, finalized on June 30, 2026, marks a total separation from the former joint venture structure.
Tradr ETFs has launched three leveraged single-stock funds, offering professional traders 200% exposure to the daily performance of Everspin Technologies, SiTime Corporation, and United Microelectronics. These Cboe-listed instruments mark the first time leveraged ETFs have been introduced specifically for Everspin and SiTime, expanding the firm’s semiconductor-focused lineup to 75 products.
Cardinal Infrastructure Group reported record-breaking second-quarter revenue of $226.9 million, a 114% year-over-year increase, while simultaneously signaling a shift toward aggressive expansion by acquiring the Atlanta-based Allied Paving and raising its full-year revenue outlook to a midpoint of $890 million.
A $59 billion hit from unfavorable market returns dragged down Invesco Ltd.’s total assets under management to $2,447.1 billion by the end of July. Despite the 0.9% monthly decline, the Atlanta-based investment firm managed to attract $8.6 billion in net long-term inflows alongside strong interest in its liquidity products.
When E.S. Halsted founded his burlap sack business in 1876, the telephone was a new invention and Colorado had just joined the Union. Today, the Cranbury-based company marks its 150th anniversary, having evolved from a Manhattan manufacturer into a global distributor of flexible industrial and food-grade packaging.
David C. Kimbell, the former chief executive of Ulta Beauty, has joined the Board of Directors at Group 1 Automotive. His appointment, effective August 10, 2026, expands the board to ten members and places the veteran retail strategist directly onto the company's Audit Committee.
Convinced that public markets are undervaluing its infrastructure, Hyperscale Data, Inc. has launched a formal review of its strategic alternatives. The Las Vegas-based firm is now weighing a potential sale or lease of its Michigan data center, a move aimed at capturing value that leadership insists remains unrecognized by current stock prices.
A securities fraud class action has been filed against Capricor Therapeutics, targeting the company's disclosure practices regarding its lead drug candidate, Deramiocel. Investors who suffered losses between December 17, 2025, and July 26, 2026, are now being urged to step forward as the court considers a lead plaintiff.
A federal securities class action lawsuit has been filed against PROCEPT BioRobotics Corporation, alleging the company artificially inflated sales figures through aggressive bulk-discount programs. Investors who purchased common stock between February 28, 2024, and February 25, 2026, are now being sought to serve as lead plaintiffs in the litigation.
Keenova Therapeutics reported a $221 million loss from continuing operations for the second quarter of 2026, a sharp decline from the prior year’s $31 million loss. Despite the deficit, the company raised its full-year growth outlook for core brands Acthar Gel and XIAFLEX, citing strong market demand.
DarioHealth reported second-quarter 2026 revenue of $5.2 million, a figure shaped by the company’s strategic exit from pharmaceutical-related services. Despite the top-line contraction, the AI-focused healthcare firm significantly improved its operational efficiency, cutting its quarterly operating loss by 11% compared to the start of the year.
With top-line data for its lead multiple sclerosis therapy expected by year-end, New York-based Immunic is restructuring its executive ranks. The biotech firm confirmed that its Phase 3 ENSURE trials remain on schedule, supported by a bolstered leadership team and a strengthened balance sheet following recent private financing.
Investors who purchased Primoris Services Corporation stock between August 5, 2025, and June 22, 2026, are seeking lead plaintiff status in a federal securities class action. The lawsuit alleges that company executives misled shareholders about the firm's ability to manage costs and risks within its renewable energy projects.
Investors who held Pentair plc stock during a period of significant volatility between April 28 and July 14, 2026, have until October 2 to apply for lead plaintiff status in a class action lawsuit, according to the legal firm Hagens Berman Sobol Shapiro LLP.
Duke Energy has priced a public offering of 35 million equity units at $50 apiece, aiming to raise $1.75 billion. The offering, slated to close on August 13, 2026, includes an over-allotment option for underwriters that could push the total proceeds to nearly $2 billion.
.jpg)
Investors holding Black Rock Coffee Bar stock face an August 17, 2026, deadline to seek lead plaintiff status in a class action lawsuit. The litigation targets the company over allegations that executives misled shareholders regarding the success of its expansion strategy following the firm's September 2025 Initial Public Offering.
Investors who purchased Cogent Communications Holdings stock between February 29, 2024, and May 1, 2026, have until September 21, 2026, to file as lead plaintiffs in a securities class action lawsuit questioning the company’s disclosures regarding its optical wavelength backlog and projected revenue growth.
A federal securities class action lawsuit now targets Regeneron Pharmaceuticals, alleging the company misled investors regarding the efficacy of a high-stakes melanoma therapy. The litigation follows a failed Phase 3 clinical trial that erased $11 billion in market capitalization and triggered a sharp decline in the company’s share price.
Investors who suffered losses in Embecta Corp. stock between November 25, 2025, and May 4, 2026, have until August 17, 2026, to file as lead plaintiffs. The class action suit centers on allegations that the company misled shareholders about the stability of its insulin pen needle business.
With nearly two decades of experience navigating complex digital transformations and regulatory landscapes, Hongyu Chen-Birkenbeul joins Vienna-based KuCoin EU as Managing Director. Her arrival signals a strategic push to bolster the MiCAR-licensed platform's technical infrastructure and operational resilience as the firm scales its footprint across the European Economic Area.
In Shenzhen, the Shoplazza DTC Summit 2026 marked a strategic pivot for the e-commerce platform, shifting from fragmented digital tools toward a unified, autonomous future. Founder and CEO Jeff Li showcased the latest evolution of Athena, an AI agent designed to manage complex storefront operations through natural language commands.
